ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
iShares MSCI Indonesia

iShares MSCI Indonesia (EIDO)

12,71
0,00
(0,00%)
Fermé 16 Juin 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

iShares MSCI Indonesia ([symbol]) Options

Achats

StrikeAchatVenteDernier PrixPoint MédianVarVar %VolumeINT OUVERTDernière Trans
8,003,905,604,304,750,000,00 %041-
9,002,954,600,003,7750,000,00 %00-
10,001,953,601,602,7750,000,00 %09-
11,001,002,550,701,7750,000,00 %065-
12,000,501,000,650,750,3085,71 %211915/6/2026
13,000,100,400,180,25-0,02-10,00 %22615/6/2026
14,000,000,450,000,000,000,00 %00-
15,000,000,800,000,000,000,00 %00-
16,000,000,800,000,000,000,00 %00-
17,000,000,800,350,350,000,00 %02-
18,000,000,800,000,000,000,00 %00-
19,000,000,300,000,000,000,00 %00-
20,000,000,800,000,000,000,00 %00-
21,000,000,800,000,000,000,00 %00-
22,000,000,800,000,000,000,00 %00-

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Ventes

StrikeAchatVenteDernier PrixPoint MédianVarVar %VolumeINT OUVERTDernière Trans
8,000,000,100,000,000,000,00 %00-
9,000,000,800,000,000,000,00 %00-
10,000,000,200,150,150,000,00 %047-
11,000,000,800,530,530,000,00 %0107-
12,000,000,800,500,500,000,00 %0355-
13,000,101,151,050,6250,000,00 %026-
14,000,452,051,501,250,000,00 %0170-
15,001,502,302,201,90-0,80-26,67 %367815/6/2026
16,002,454,102,753,2750,000,00 %01-
17,003,405,100,004,250,000,00 %00-
18,004,406,100,005,250,000,00 %00-
19,005,407,100,006,250,000,00 %00-
20,006,408,100,007,250,000,00 %00-
21,007,409,100,008,250,000,00 %00-
22,008,4010,100,009,250,000,00 %00-

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AACIUArmada Acquisition Corporation III
US$ 10,30
(0,00%)
0
AACIArmada Acquisition Corporation III
US$ 9,96
(0,00%)
0
AACGATA Creativity Global
US$ 1,01
(0,00%)
0
AACBUArtius II Acquisition Inc
US$ 10,61
(0,00%)
0
AACBArtius II Acquisition Inc
US$ 10,51
(0,00%)
0
AACIUArmada Acquisition Corporation III
US$ 10,30
(0,00%)
0
AACIArmada Acquisition Corporation III
US$ 9,96
(0,00%)
0
AACGATA Creativity Global
US$ 1,01
(0,00%)
0
AACBUArtius II Acquisition Inc
US$ 10,61
(0,00%)
0
AACBArtius II Acquisition Inc
US$ 10,51
(0,00%)
0
AACIUArmada Acquisition Corporation III
US$ 10,30
(0,00%)
0
AACIArmada Acquisition Corporation III
US$ 9,96
(0,00%)
0
AACGATA Creativity Global
US$ 1,01
(0,00%)
0
AACBUArtius II Acquisition Inc
US$ 10,61
(0,00%)
0
AACBArtius II Acquisition Inc
US$ 10,51
(0,00%)
0
muee88 muee88 il y a 9 minutes
“Our corporate headquarters are located at 4800 Montgomery Lane, Bethesda, Maryland, where we lease and occupy an aggregate of approximately 7,097 square feet of office space. The lease covering this property is currently scheduled to expire in August 2026.”

Well the property marketin
NWBO
eagle8 eagle8 il y a 12 minutes
https://www.gov.uk/government/news/unique-liaison-programme-set-to-reinforce-close-collaboration-between-mhra-and-fda?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=95982d69-cc79-409a-a44a-cac5e2e70ff4&utm_content=immediately
NWBO
US Market News US Market News il y a 13 minutes
KBR Launches Inaugural Innovation Studio Powered by Applied Computing in BengaluruJune 16, 2026 3:35 AM
PR Newswire (US) class="legendSpanClass"BENGALURU, India, class="legendSpanClass"June 16, 2026 /PRNewswire/ -- KBR (NYSE: KBR) launch
KBR
tkg tkg il y a 15 minutes
I don't see any end in sight for the insatiable demand for compute and data centers, to the contrary, demand is going parabolic.

Qualcomm CEO says AI agents will replace apps — as chip giant works on 40 new AI-powered devices
PUBLISHED TUE, JUN 16 20261:08 AM EDT

LWLG
knrorrel knrorrel il y a 15 minutes
GPUS Everyone should keep an eye on this one; GPUS should continue to rise over the coming days and weeks. And once a deal is announced, the stock’s real future should truly take off—driven by strong revenue and massive profits. imho ,🚀 https://investorshub.advfn.com/boards/read_msg.aspx?me
GPUS
silattore silattore il y a 15 minutes
WOW! Umpteenth dilution. Another umpteenth times to go. Well done.
Didn't know being a CEO and managing a company is this easy, as far as AMC is concerned. You earn money or lose money, doesn't matter. There is always dilution.

If retail shareholders oppose another dilution, t
AMC
knrorrel knrorrel il y a 16 minutes
GPUS
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177706706
GPUS
knrorrel knrorrel il y a 16 minutes
GPUS Everyone should keep an eye on this one; GPUS should continue to rise over the coming days and weeks. And once a deal is announced, the stock’s real future should truly take off—driven by strong revenue and massive profits. imho ,🚀 https://investorshub.advfn.com/boards/read_msg.aspx?me
GPUS
CelestialSage6 CelestialSage6 il y a 27 minutes
Yes, I understand. Even if you combine all of that, can it beat Dupixent? Alteogen only collaborates with the best companies. On the other hand, Halozyme has signed contracts with companies that I don't even know if they are actually working with. So, it's not Alteogen signing with junk, but Halozym
HALO
CA Market News CA Market News il y a 28 minutes
Herbal Dispatch Provides Update on Domestic Retail Operations and Proprietary Brand ExpansionJune 16, 2026 3:01 AM
NewsfileVancouver, B
LUFFF
tkg tkg il y a 33 minutes
The Strategic Verdict

This Forbes article is a massive structural validation for long-term Lightwave shareholders. For years, the bears argued that Lightwave was a standalone science project trying to force its way into the market.

Now, the U.S. government and GlobalFou
LWLG
Hellie Hellie il y a 36 minutes
11/06 , maybe you're right!
LWLG
biotechinvestor1 biotechinvestor1 il y a 39 minutes
Here are a few of those drugs:
Ebglyss (IL-13)Adbry (IL-13)Nemluvio (IL-31 receptor)Late-stage agents such as zumilokibart. 
HALO
Henk van vleuten Henk van vleuten il y a 40 minutes
When was it publiced? Maybe this why on 12june there was a huge spike on Jan 2027 15 options??
LWLG
biotechinvestor1 biotechinvestor1 il y a 41 minutes
You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:
HALO
God Bless America God Bless America il y a 42 minutes
Of course they did not buy because they knew the regulation. Their families did buy instead.
FNMA
US Market News US Market News il y a 42 minutes
Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2026June 16, 2026 3:00 AM
PR Newswire (US) class="legendSpanClass"BEIJING, class="legendSpanClass"June 16, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company
UXIN
US Market News US Market News il y a 42 minutes
DXC Expands Relationship with Norske Skog to Modernize Network and Technology OperationsJune 16, 2026 3:00 AM
PR Newswire (US) Multi-year partnership delivers a modern, secure network solution while broadening DXC's role across Norske Sko
DXC
US Market News US Market News il y a 43 minutes
Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and InfrastructureJune 16, 2026 3:00 AM
PR Newswire (US) The company's revolutionary, pate
STI
US Market News US Market News il y a 43 minutes
Elite Tech, Accessible Price - Introducing the Logitech G3 Series Mouse and Keyboard for PC GamingJune 16, 2026 3:05 AM
Business Wire Elite Precision - Unleash pro-grade speed with the G305 X SUPERLIGHT gaming mouse and G316 X 98 gaming keyboard. Featur
LOGI
biotechinvestor1 biotechinvestor1 il y a 46 minutes
You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:
Late-stage agents such as zumilokibar
HALO
US Market News US Market News il y a 58 minutes
Unilever Scales Digital Twins Across Global Manufacturing Network with AccentureJune 16, 2026 2:59 AM
Business WireUnilever (LON: ULVR) is partnering with Accenture (NYSE: ACN) to scale the use of AI-enabled digital twins across its global manufacturing network
ACN
CelestialSage6 CelestialSage6 il y a 1 heure
You can't refute it. Yes, I understand your level well.
HALO
biotechinvestor1 biotechinvestor1 il y a 1 heure
Total nonsense! I have no interest in educating you.
HALO